Delivery Order SPE2DR25D7059-SPE2DR26F7MRJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Junel 1.5 mg-30 mcg tablets in quantities of 21 units, with a ceiling value of $1,141.83 and an ultimate completion date of December 3, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Junel FE 1.5mg contraceptive medication in a 168-tablet quantity. This competitively awarded, non-set-aside contract carries a ceiling value of $9,225.44 with firm fixed pricing and is scheduled for completion by January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.91 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single pharmaceutical delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,285.28 to AmerisourceBergen Drug Corp on August 15, 2025, for Junel FE 1mg-20 168s pharmaceutical product. This is a firm fixed price, non-competitive delivery order under a larger indefinite delivery contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.20 to AmerisourceBergen Drug Corp for the supply of Junel 1.5 mg-30 mcg tablets (21-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,772.81 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg–30 mcg tablets (28-count packages) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,318.84 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Junel FE 1mg-20 168s pharmaceutical product, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price delivery order is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. The award carries no set-aside designation and is classified as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-tablet package configuration. This firm fixed-price delivery order, valued at $1,141.06, represents a non-set-aside competitive award with an ultimate completion date of May 20, 2025. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1MG-20 168S pharmaceutical product. This firm fixed price, non-competitive delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under the company's larger...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MRJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,453.52 on December 5, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units. The contract represents a firm fixed-price, non-set-aside delivery order with performance completion scheduled for December 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract vehicle provides comprehensive global pharmaceutical support, enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contracting history demonstrates consistent success in competitive procurement processes, with delivery orders ranging significantly in value and spanning diverse pharmaceutical product categories. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple award opportunities across separate regions, reflecting the strategic importance of reliable pharmaceutical distribution to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/4/25 |